The Ritchie Centre, Monash Institute of Medical Research-Prince Henry's Institute, Melbourne, Clayton, Victoria, Australia; and.
The Ritchie Centre, Monash Institute of Medical Research-Prince Henry's Institute, Melbourne, Clayton, Victoria, Australia; and Department of Obstetrics and Gynaecology, Monash University, Melbourne, Victoria, Australia;
Am J Physiol Regul Integr Comp Physiol. 2014 Jun 1;306(11):R773-86. doi: 10.1152/ajpregu.00487.2013. Epub 2014 Mar 19.
Cerebrovascular lesions, mainly germinal matrix hemorrhage and ischemic injury to the periventricular white matter, are major causes of adverse neurodevelopmental outcome in preterm infants. Cerebrovascular lesions and neuromorbidity increase with decreasing gestational age, with the white matter predominantly affected. Developmental immaturity in the cerebral circulation, including ongoing angiogenesis and vasoregulatory immaturity, plays a major role in the severity and pattern of preterm brain injury. Prevention of this injury requires insight into pathogenesis. Cerebral blood flow (CBF) is low in the preterm white matter, which also has blunted vasoreactivity compared with other brain regions. Vasoreactivity in the preterm brain to cerebral perfusion pressure, oxygen, carbon dioxide, and neuronal metabolism is also immature. This could be related to immaturity of both the vasculature and vasoactive signaling. Other pathologies arising from preterm birth and the neonatal intensive care environment itself may contribute to impaired vasoreactivity and ineffective CBF regulation, resulting in the marked variations in cerebral hemodynamics reported both within and between infants depending on their clinical condition. Many gaps exist in our understanding of how neonatal treatment procedures and medications have an impact on cerebral hemodynamics and preterm brain injury. Future research directions for neuroprotective strategies include establishing cotside, real-time clinical reference values for cerebral hemodynamics and vasoregulatory capacity and to demonstrate that these thresholds improve long-term outcomes for the preterm infant. In addition, stimulation of vascular development and repair with growth factor and cell-based therapies also hold promise.
脑血管病变,主要为脑室内出血和脑室周围白质的缺血性损伤,是早产儿不良神经发育结局的主要原因。脑血管病变和神经病变随着胎龄的降低而增加,以白质为主。脑循环发育不成熟,包括持续的血管生成和血管调节不成熟,在早产儿脑损伤的严重程度和模式中起着重要作用。预防这种损伤需要深入了解发病机制。早产儿脑白质的脑血流量 (CBF) 较低,与其他脑区相比,其血管反应性也较差。早产儿脑对脑灌注压、氧、二氧化碳和神经元代谢的血管反应也不成熟。这可能与脉管系统和血管活性信号的不成熟有关。早产儿出生和新生儿重症监护环境本身引起的其他病理可能导致血管反应性受损和 CBF 调节无效,导致根据其临床状况,报告的脑血流动力学在个体内部和个体之间存在明显差异。我们对新生儿治疗程序和药物如何影响脑血流动力学和早产儿脑损伤的理解还存在许多空白。神经保护策略的未来研究方向包括建立床边、实时的脑血流动力学和血管调节能力的临床参考值,并证明这些阈值可以改善早产儿的长期结局。此外,用生长因子和基于细胞的治疗来刺激血管发育和修复也具有很大的希望。